Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and NephrocalcinosisDebayan Dasgupta, Clemens Bergwitz, Karl P. Schlingmann et al.|Journal of the American Society of Nephrology|2014Cited by 172
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Burkhard Tönshoff et al.|Kidney International|2020Cited by 151
Biallelic variants in <scp><i>ZNF142</i></scp> lead to a syndromic neurodevelopmental disorderMaria Bejerholm Christensen, Juliane Winkelmann, Amanda M. Levy et al.|Clinical Genetics|2022Cited by 16